143 related articles for article (PubMed ID: 37285240)
1. Steroid Phobia in Patients With Vulvar Lichen Sclerosus.
Delpero E; Sriharan A; Selk A
J Low Genit Tract Dis; 2023 Jul; 27(3):286-290. PubMed ID: 37285240
[TBL] [Abstract][Full Text] [Related]
2. Topical Corticosteroid Phobia Among Women Affected With Vulvar Lichen Sclerosus: Results From a Cross-sectional Survey.
Borghi A; Flacco ME; Pacetti L; Toni G; Corazza M
J Low Genit Tract Dis; 2024 Apr; 28(2):169-174. PubMed ID: 38346422
[TBL] [Abstract][Full Text] [Related]
3. Long-term Management of Adult Vulvar Lichen Sclerosus: A Prospective Cohort Study of 507 Women.
Lee A; Bradford J; Fischer G
JAMA Dermatol; 2015 Oct; 151(10):1061-7. PubMed ID: 26070005
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of prescribing topical corticosteroids to patients with lichen sclerosus following surgery for vulvar cancer: a survey among gynaecologic oncologists in The Netherlands.
Voss FO; Groenewegen KL; Vermaat H; Bleeker MCG; van Beurden M
J Obstet Gynaecol; 2024 Dec; 44(1):2294330. PubMed ID: 38156715
[TBL] [Abstract][Full Text] [Related]
5. Does compliance to topical corticosteroid therapy reduce the risk of development of permanent vulvar structural abnormalities in pediatric vulvar lichen sclerosus? A retrospective cohort study.
Kherlopian A; Fischer G
Pediatr Dermatol; 2022 Jan; 39(1):22-30. PubMed ID: 34738263
[TBL] [Abstract][Full Text] [Related]
6. Attitudes Toward Proactive Topical Corticosteroid Use Among Women With Vulval Lichen Sclerosus.
Rees S; Arnold S; Kherlopian A; Fischer G
J Low Genit Tract Dis; 2024 Apr; 28(2):183-188. PubMed ID: 38518216
[TBL] [Abstract][Full Text] [Related]
7. Risk of Development of Vulvar Cancer in Women With Lichen Sclerosus or Lichen Planus: A Systematic Review.
Vieira-Baptista P; Pérez-López FR; López-Baena MT; Stockdale CK; Preti M; Bornstein J
J Low Genit Tract Dis; 2022 Jul; 26(3):250-257. PubMed ID: 35285455
[TBL] [Abstract][Full Text] [Related]
8. Assessment of topical steroid phobia in dermatology patients, a cross-sectional study from an urban area of Pakistan.
Masood S; Jalil P; Awan S; Ghulam U; Kerawala SR
J Dermatolog Treat; 2022 Jun; 33(4):2331-2334. PubMed ID: 34334088
[TBL] [Abstract][Full Text] [Related]
9. Novel Therapeutic Approaches and Targets for Treatment of Vulvar Lichen Sclerosus.
Borghi A; Corazza M
Curr Pharm Biotechnol; 2021; 22(1):99-114. PubMed ID: 32416670
[TBL] [Abstract][Full Text] [Related]
10. Mid-term symptomatic relief after platelet-rich plasma infiltration in vulvar lichen sclerosus.
Medina Garrido C; Cano García A; de la Cruz Cea L; Oreja Cuesta AB
Arch Dermatol Res; 2023 Aug; 315(6):1527-1532. PubMed ID: 36656384
[TBL] [Abstract][Full Text] [Related]
11. Fractional CO
Stewart K; Javaid S; Schallen KP; Bartlett S; Carlson NA
Lasers Surg Med; 2022 Jan; 54(1):138-151. PubMed ID: 34541702
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes and adherence to topical corticosteroid therapy in women with vulvar lichen sclerosus: A retrospective cohort study.
Kohn JR; Connors TM; Chan W; Liang CS; Dao H; Vyas A
J Am Acad Dermatol; 2020 Oct; 83(4):1104-1109. PubMed ID: 32387654
[TBL] [Abstract][Full Text] [Related]
13. Comorbid Vulvar Lichen Sclerosus and High-Grade Squamous Intraepithelial Lesions: A Management Conundrum.
Janke MJ; DeBlanc J; Kobernik EK; Skala SL; Hiles GL; Kelly R; Welch KC
J Low Genit Tract Dis; 2022 Oct; 26(4):319-322. PubMed ID: 35972920
[TBL] [Abstract][Full Text] [Related]
14. UV-A1 phototherapy vs clobetasol propionate, 0.05%, in the treatment of vulvar lichen sclerosus: a randomized clinical trial.
Terras S; Gambichler T; Moritz RK; Stücker M; Kreuter A
JAMA Dermatol; 2014 Jun; 150(6):621-7. PubMed ID: 24696010
[TBL] [Abstract][Full Text] [Related]
15. RF - Importance of Topical Corticosteroid Treatment for Vulvar Lichen Sclerosus to Prevent Recurrences of Vulvar Carcinoma.
Luque-Luna M; Bosch-Amate X; Morgado-Carrasco D
Actas Dermosifiliogr; 2022; 113(7):722-723. PubMed ID: 35461636
[No Abstract] [Full Text] [Related]
16. Efficacy of topical progesterone versus topical clobetasol propionate in patients with vulvar Lichen sclerosus - A double-blind randomized phase II pilot study.
Günthert AR; Limacher A; Beltraminelli H; Krause E; Mueller MD; Trelle S; Bobos P; Jüni P
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():88-95. PubMed ID: 35290878
[TBL] [Abstract][Full Text] [Related]
17. Nd:YAG/Er:YAG dual laser compared with topical steroid to treat vulvar lichen sclerosus: A randomised controlled trial.
Zivanovic I; Gamper M; Fesslmeier D; Walser C; Regauer S; Viereck V
BJOG; 2024 May; 131(6):740-749. PubMed ID: 38149520
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid phobia: a questionnaire study using TOPICOP score.
Choi E; Chandran NS; Tan C
Singapore Med J; 2020 Mar; 61(3):149-153. PubMed ID: 32488277
[TBL] [Abstract][Full Text] [Related]
19. Topical interventions for genital lichen sclerosus.
Chi CC; Kirtschig G; Baldo M; Brackenbury F; Lewis F; Wojnarowska F
Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD008240. PubMed ID: 22161424
[TBL] [Abstract][Full Text] [Related]
20. Clinical and dermoscopic changes of vulvar lichen sclerosus after topical corticosteroid treatment.
Borghi A; Corazza M; Minghetti S; Toni G; Virgili A
J Dermatol; 2016 Sep; 43(9):1078-82. PubMed ID: 27075682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
